Cargando…

Pseudogene legumain promotes thyroid carcinoma progression via the microRNA-495/autophagy pathway

The pseudogene legumain (LGMN) has been reported to regulate cancer cell biology. However, the role of LGMN in thyroid carcinoma remains unknown. Herein, Cell Counting Kit 8 and Transwell assays were performed to evaluate cellular proliferation and invasion capacity, respectively. In addition, a tub...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jie, Peng, Yicheng, Liu, Jianxia, Zhou, Hao, Sun, Liang, He, Qin, Yu, Enqiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243076/ https://www.ncbi.nlm.nih.gov/pubmed/34257724 http://dx.doi.org/10.3892/ol.2021.12877

Ejemplares similares

Legumain Promotes Atherosclerotic Vascular Remodeling
por: Ozawa, Nana, et al.
Publicado: (2019)

NLRP3 Inflammasome Activation by MicroRNA-495 Promoter Methylation May Contribute to the Progression of Acute Lung Injury
por: Ying, Youguo, et al.
Publicado: (2019)

Long Noncoding RNA UCA1 Regulates PRL-3 Expression by Sponging MicroRNA-495 to Promote the Progression of Gastric Cancer
por: Cao, Yi, et al.
Publicado: (2019)

Legumain promotes tubular ferroptosis by facilitating chaperone-mediated autophagy of GPX4 in AKI
por: Chen, Chuan’ai, et al.
Publicado: (2021)

Prognostic value of legumain in uveal melanoma
por: WU, TONG, et al.
Publicado: (2016)

Retraction Notice to: Long Noncoding RNA UCA1 Regulates PRL-3 Expression by Sponging MicroRNA-495 to Promote the Progression of Gastric Cancer
por: Cao, Yi, et al.
Publicado: (2022)

Hypoxia-driven protease legumain promotes immunosuppression in glioblastoma
por: Pang, Lizhi, et al.
Publicado: (2023)

Legumain Promotes Gastric Cancer Progression Through Tumor-associated Macrophages In vitro and In vivo
por: Wang, Hongbin, et al.
Publicado: (2020)

MicroRNA 495 Inhibits Proliferation and Metastasis and Promotes Apoptosis by Targeting Twist1 in Gastric Cancer Cells
por: Liu, Chao, et al.
Publicado: (2019)

MicroRNA-495 induces breast cancer cell migration by targeting JAM-A
por: Cao, Minghui, et al.
Publicado: (2014)

MicroRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer
por: Xu, Yan-Ying, et al.
Publicado: (2015)

A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple‐negative breast cancer
por: Sun, Jie, et al.
Publicado: (2021)

The pseudogene TUSC2P promotes TUSC2 function by binding multiple microRNAs
por: Rutnam, Zina Jeyapalan, et al.
Publicado: (2014)

MicroRNA-495-3p inhibits multidrug resistance by modulating autophagy through GRP78/mTOR axis in gastric cancer
por: Chen, Sheng, et al.
Publicado: (2018)

Expression of Legumain Correlates with Prognosis and Metastasis in Gastric Carcinoma
por: Guo, Pengtao, et al.
Publicado: (2013)

MicroRNA‐495‐3p diminishes doxorubicin‐induced cardiotoxicity through activating AKT
por: Meng, Jun, et al.
Publicado: (2022)

MicroRNA-495 suppresses pre-eclampsia via activation of p53/PUMA axis
por: Zhao, Yi, et al.
Publicado: (2022)

Nuclear Legumain Activity in Colorectal Cancer
por: Haugen, Mads H., et al.
Publicado: (2013)

Roles of Species-Specific Legumains in Pathogenicity of the Pinewood Nematode Bursaphelenchus xylophilus
por: Zhang, Xi, et al.
Publicado: (2022)

MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6
por: Chen, Shu-Mei, et al.
Publicado: (2013)

Correction: Nuclear Legumain Activity in Colorectal Cancer
por: Haugen, Mads H., et al.
Publicado: (2013)

The Mammalian Cysteine Protease Legumain in Health and Disease
por: Solberg, Rigmor, et al.
Publicado: (2022)

MicroRNA-495 Inhibits New Bone Regeneration via Targeting High Mobility Group AT-Hook 2 (HMGA2)
por: Tian, Zhao, et al.
Publicado: (2017)

Active legumain promotes invasion and migration of neuroblastoma by regulating epithelial-mesenchymal transition
por: Zhang, Min, et al.
Publicado: (2022)

Neuronal-expressed microRNA-targeted pseudogenes compete with coding genes in the human brain
por: Barbash, S, et al.
Publicado: (2017)

Legumain Functions as a Transient TrkB Sheddase
por: Holzner, Christoph, et al.
Publicado: (2023)

MicroRNA-495 serves as a diagnostic biomarker in patients with sepsis and regulates sepsis-induced inflammation and cardiac dysfunction
por: Guo, Hailei, et al.
Publicado: (2019)

Downregulation of MicroRNA-495 Alleviates IL-1β Responses among Chondrocytes by Preventing SOX9 Reduction
por: Joung, Soyeong, et al.
Publicado: (2021)

MON-495 Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma
por: Viola, Nicola, et al.
Publicado: (2020)

Simvastatin Inhibits Glucose Metabolism and Legumain Activity in Human Myotubes
por: Smith, Robert, et al.
Publicado: (2014)

Structure and Mechanism of an Aspartimide-Dependent Peptide Ligase in Human Legumain**
por: Dall, Elfriede, et al.
Publicado: (2015)

High Plasma Levels of Legumain in Patients with Complex Coronary Lesions
por: Umei, Tomohiko C., et al.
Publicado: (2020)

Knockdown of Legumain Suppresses Cervical Cancer Cell Migration and Invasion
por: Meng, Fei, et al.
Publicado: (2016)

Pseudogenes
por: Tutar, Yusuf
Publicado: (2012)

Marine-Derived Natural Product HDYL-GQQ-495 Targets P62 to Inhibit Autophagy
por: Li, Quanfu, et al.
Publicado: (2023)

Long non-coding RNA (lncRNA) nuclear enriched abundant transcript 1 (NEAT1) promotes the inflammation and apoptosis of otitis media with effusion through targeting microRNA (miR)-495 and activation of p38 MAPK signaling pathway
por: Hu, Yajuan, et al.
Publicado: (2021)

Association of the Single Nucleotide Polymorphisms in microRNAs 130b, 200b, and 495 with Ischemic Stroke Susceptibility and Post-Stroke Mortality
por: Kim, Jinkwon, et al.
Publicado: (2016)

MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1
por: Ye, Ying, et al.
Publicado: (2022)

Clonorchis sinensis legumain promotes migration and invasion of cholangiocarcinoma cells via regulating tumor-related molecules
por: Chu, Yanfei, et al.
Publicado: (2023)

Cystatin E/M suppresses legumain activity and invasion of human melanoma
por: Briggs, Jon J, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_i6spnocoffq0718lsm0tqv2guk